Goodwill
Labcorp Holdings Goodwill increased by 2.4% to $6.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $6.42B to $6.96B. Over 5 years (FY 2020 to FY 2025), Goodwill shows a downward trend with a -2.6% CAGR.
Analysis
How to read this metric
A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.
Detailed definition
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Peer comparison
Standard metric for companies that grow through acquisition; comparable across all industries.
goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.74B | $7.91B | $5.89B | $8.17B | $8.11B | $8.22B | $6.12B | $8.12B | $6.18B | $6.33B | $6.14B | $6.22B | $6.22B | $6.48B | $6.37B | $6.42B | $6.55B | $6.68B | $6.79B | $6.96B |
| QoQ Change | — | +2.1% | -25.5% | +38.6% | -0.6% | +1.3% | -25.5% | +32.5% | -23.8% | +2.4% | -3.0% | +1.2% | +0.0% | +4.2% | -1.7% | +0.8% | +2.0% | +2.0% | +1.6% | +2.4% |
| YoY Change | — | — | — | — | +4.8% | +3.9% | +4.0% | -0.6% | -23.8% | -22.9% | +0.3% | -23.4% | +0.6% | +2.4% | +3.7% | +3.3% | +5.3% | +3.1% | +6.6% | +8.3% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Diagnostics | — | — | $5.10B | — | $5.17B | $5.33B | $5.43B | $5.61B |
| Biopharma Laboratory Services | — | — | $1.27B | — | $1.39B | $1.35B | $1.35B | $1.35B |
| Covance Drug Development | $1.28B | $1.33B | — | $1.29B | — | — | — | — |
| LabCorp Diagnostics | $4.94B | $5.15B | — | $5.13B | — | — | — | — |
| Total | $6.22B | $6.48B | $6.37B | $6.42B | $6.55B | $6.68B | $6.79B | $6.96B |
Covance Drug Development, LabCorp Diagnostics were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Goodwill at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's goodwill?
- Labcorp Holdings (LH) reported goodwill of $6.96B in Q1 2026.
- How has Labcorp Holdings's goodwill changed year-over-year?
- Labcorp Holdings's goodwill increased by 8.3% year-over-year, from $6.42B to $6.96B.
- What is the long-term trend for Labcorp Holdings's goodwill?
- Over 5 years (2020 to 2025), Labcorp Holdings's goodwill has grown at a -2.6% compound annual growth rate (CAGR), from $7.75B to $6.79B.
- What does goodwill mean?
- The excess price paid for an acquisition over the fair value of its net assets.